Pei-qin Wang
Changzheng, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Rifaximin treatment shapes a unique metagenome-metabolism network in patients with decompensated cirrhosis.
Journal: Journal of gastroenterology and hepatology
Published: September 07, 2023
Fecal Signatures of Streptococcus anginosus and Streptococcus constellatus for Noninvasive Screening and Early Warning of Gastric Cancer.
Journal: Gastroenterology
Published: August 05, 2021
Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis.
Journal: Hepatology international
Published: August 01, 2020
New formula for predicting standard liver volume in Chinese adults.
Journal: World journal of gastroenterology
Published: December 27, 2016
Differentiation therapy of hepatocellular carcinoma by inhibiting the activity of AKT/GSK-3β/β-catenin axis and TGF-β induced EMT with sophocarpine.
Journal: Cancer letters
Published: June 16, 2015
The cytotoxic and mechanistic effects of aaptamine on hepatocellular carcinoma.
Journal: Anti-cancer agents in medicinal chemistry
Published: October 17, 2014
Hepatocyte nuclear factor 4α-nuclear factor-κB feedback circuit modulates liver cancer progression.
Journal: Hepatology (Baltimore, Md.)
Published: December 21, 2013
Hepatocyte nuclear factor-4α reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 region.
Journal: Hepatology (Baltimore, Md.)
Published: February 06, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026